The Alberta government closed Calgary's only supervised consumption site on Tuesday, June 30, 2026 [1].
The closure removes the city's sole designated facility for supervised drug use, marking a significant shift in how the province manages addiction and overdose prevention. This move signals a transition away from harm-reduction services in favor of clinical recovery models.
The site, known as Safeworks Outreach, operated within the Sheldon M. Chumir Health Centre [1, 2]. Provincial officials said the administration under Premier Danielle Smith is redirecting funding from these supervised consumption sites to treatment centres [1, 3].
Calgary previously relied on this single location [1] to provide a controlled environment where individuals could use substances under medical supervision to prevent fatal overdoses. The sudden loss of the facility leaves a gap in the city's immediate emergency response to the opioid crisis.
While the site officially shut its doors on Tuesday [1], the move has sparked immediate tension. Some reports indicate the Alberta government may face further legal challenges from advocates seeking to keep such sites operational [4].
Opponents of the closure argue that removing supervised sites increases the risk of public drug use and unattended overdoses. The government said the priority is now shifting toward long-term recovery, and treatment infrastructure [1, 3].
This closure follows a broader provincial strategy to prioritize abstinence-based treatment over the supervised use of illicit substances. The transition is part of a wider policy overhaul by the Smith administration to change the delivery of healthcare services related to substance use [1, 3].
“The Alberta government closed Calgary's only supervised consumption site on Tuesday, June 30, 2026.”
This policy shift represents a fundamental move by the Alberta government to prioritize treatment-led recovery over harm reduction. By closing the only supervised consumption site in Calgary, the province is testing a model that emphasizes clinical intervention over the mitigation of immediate overdose risks in the community.



